G. Gallick

N. Donato, G. Gallick, M. Davies, 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Carcinomas of the Head and Neck Activity in Human Cell Lines Established from Squamous Epidermal Growth Factor Receptor Protein-Tyrosine Kinase Updated

J. Gutterman, S. Maxwell, G. Gallick, 2006 .

Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neck.

J. Gutterman, S. Maxwell, G. Gallick, 1989, Cancer research.

Pyrimido‐pyrimidine modulation of EGF growth‐promoting activity and p21ras expression in rat mammary adenocarcinoma cells

G. Nicolson, G. Gallick, R. Lichtner, 1988, Journal of cellular physiology.

Effect of Epidermal Growth Factor (EGF) on a Newly Established Head and Neck Squamous Carcinoma Cell Line

R. Weber, S. Pathak, G. Gallick, 1988, Otolaryngology Head & Neck Surgery.

Transcriptional Induction of the Urokinase Receptor Gene by a Constitutively Active Src

H. Allgayer, Hong Wang, A. Kraker, 1999, The Journal of Biological Chemistry.

Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes in Vitro Colon Cancer Invasiveness

H. Kessler, D. Boyd, G. Gallick, 2004, Clinical Cancer Research.

Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells.

R. Lotan, W. Hong, P. Steck, 1992, Journal of the National Cancer Institute. Monographs.

AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes

J. Trevino, T. Sawyer, W. Shakespeare, 2005, Molecular Cancer Therapeutics.

A group of temperature-sensitive mutants of Moloney leukemia virus which is defective in cleavage of env precursor polypeptide in infected cells also induces hind-limb paralysis in newborn CFW/D mice.

G. Gallick, P. Wong, M. Soong, 1983, Virology.

Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude mice.

I. Fidler, J. Trevino, G. Gallick, 2006, International journal of oncology.

Targeting Src in Mucinous Ovarian Carcinoma

P. Ram, K. Komurov, A. Sood, 2011, Clinical Cancer Research.

Functional Roles of Src and Fgr in Ovarian Carcinoma

A. Sood, Jeong-Won Lee, Hye-Sun Kim, 2011, Clinical Cancer Research.

Dasatinib and docetaxel combination treatment for patients with castration-resistant progressive prostate cancer: A phase I/II study (CA180086).

A. Armstrong, C. Logothetis, E. Posadas, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells

O. Stoeltzing, Wenbiao Liu, F. Fan, 2005, British Journal of Cancer.

Overexpression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: Independence from c-src or c-yes activation

S. Curley, G. Gallick, N. Han, 2006, Annals of Surgical Oncology.

Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.

C. Staley, G. Gallick, N. Parikh, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Editor's Note: Targeting Src in Mucinous Ovarian Carcinoma

P. Ram, K. Komurov, A. Sood, 2021, Clinical Cancer Research.

Nuclear PTEN-Mediated Growth Suppression Is Independent of Akt Down-Regulation

W. Yung, Xiaoyang Sheng, G. Gallick, 2005, Molecular and Cellular Biology.

Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation

N. Donato, C. Ince, M. Rosenblum, 1989, Journal of cellular biochemistry.

Site-specific differences in pp60c-src activity in human colorectal metastases.

S. Curley, M. Talamonti, M. Saboorian, 1993, The Journal of surgical research.

Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis

S. Kopetz, G. Gallick, Michael P. Kim, 2008, Cell and Tissue Research.

Trisomy 12 correlates with elevated expression of p21 ras in a human adenosquamous carcinoma of the lung.

R. Kurzrock, G. Gallick, J. Gutterman, 1986, Cancer genetics and cytogenetics.

c-Src Regulates Constitutive and EGF-mediated VEGF Expression in Pancreatic Tumor Cells Through Activation of Phosphatidyl Inositol-3 Kinase and p38 MAPK

J. Trevino, G. Gallick, C. Baker, 2005, Pancreas.

Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by activity of src kinase.

W. Liu, C. Staley, G. Gallick, 1997, Surgery.

Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma.

G. Hortobagyi, J. Gutterman, G. Gallick, 1988, Cancer research.

Lack of correlation between intercellular junctional communication, p21rasEJ expression, and spontaneous metastatic properties of rat mammary cells after transfection with c-H-rasEJ or neo genes.

G. Nicolson, M. Tainsky, G. Gallick, 1990, Oncogene.

Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver

F. Fan, G. Buren, G. Lopez-Berestein, 2008, Oncogene.

Potentially inappropriate medications defined by STOPP criteria in older patients with breast and colorectal cancer.

Michael L. Johnson, R. Bast, S. Cantor, 2019, Journal of geriatric oncology.

Targeting DNA damage response in prostate cancer through inhibition of androgen receptor/CDC6-ATR-Chk1 signaling

B. Broom, P. Troncoso, T. Thompson, 2017 .

Potassium inhibition of transforming protein P85gag‐mos and reversal of the transformed phenotype in 6m2 cells

F. Becker, S. Maxwell, B. Brinkley, 1988, Journal of cellular physiology.

Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer.

J. Roth, A. Gazdar, K. Fang, 1992, Surgical oncology.

The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study

R. Millikan, C. Logothetis, P. Corn, 2016, BMC Cancer.

Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

G. Gallick, Serk In Park, Gary E. Gallick, 2007, Annals of Surgical Oncology.

Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines.

H. Saya, G. Gallick, R. Garcia, 1991, Oncogene.

Inhibitors of protein tyrosine kinases

V. Levin, R. Newman, J. Ellman, 1995 .

SRC inhibitors as potential therapeutic agents for human cancers.

J. Trevino, G. Gallick, J. Summy, 2006, Mini reviews in medicinal chemistry.

Stress Hormones Regulate Interleukin-6 Expression by Human Ovarian Carcinoma Cells through a Src-dependent Mechanism*

A. Sood, S. Cole, Yang Li, 2007, Journal of Biological Chemistry.

Modification of cell surface glycoproteins, macrophage cytostasis, and blood-borne metastatic properties of the murine RAW117 large cell lymphoma by virus superinfection.

T. Irimura, G. Nicolson, G. Gallick, 1987, Cancer research.

Gene expression and tumor cell escape from host effector mechanisms in murine large cell lymphoma

T. Irimura, G. Nicolson, G. Gallick, 1988, Journal of cellular biochemistry.

Recognition of mos-related proteins with an antiserum to a peptide of the v-mos gene product.

S. Maxwell, J. Sparrow, R. Arlinghaus, 1985, The Journal of general virology.

Preliminary characterization of a temperature-sensitive mutant of Moloney murine leukemia virus that produces particles at the restrictive temperature

G. Gallick, P. Wong, 1978, Journal of virology.

Insulinlike Growth Factor-I–Mediated Migration and Invasion of Human Colon Carcinoma Cells Requires Activation of c-Met and Urokinase Plasminogen Activator Receptor

Lee M Ellis, L. Ellis, Wenbiao Liu, 2005, Annals of surgery.

Src family kinases in tumor progression and metastasis

G. Gallick, Justin M. Summy, Gary E. Gallick, 2003, Cancer and Metastasis Reviews.

Bacterial expression of an active tyrosine kinase from a protein A/truncated c‐src fusion protein

H. Saya, V. Levin, M. Nakajima, 1993, FEBS letters.

The biology of colorectal carcinoma.

G. Gallick, J. Jessup, Gary E. Gallich, 1992, Current problems in cancer.

Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck.

S. Pathak, D. Parsons, S. Parnes, 1988, Cancer research.

Monoclonal antibody study of the subcellular localization and DNA-stimulating activity of murine sarcoma virus-activated transformation-associated proteins.

G. Gallick, W. Li, K. Chi, 1987, Virology.

Targeting Src and Tubulin in Mucinous Ovarian Carcinoma

K. Baggerly, A. Sood, C. Ivan, 2013, Clinical Cancer Research.

Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players

G. Gallick, Michael P. Kim, Gary E Gallick, 2008, Clinical Cancer Research.

Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer

Wenjun Chang, Likun Li, Spyridon Basourakos, 2017, Science Signaling.

Epithelial to mesenchymal transition in head and neck squamous carcinoma

Mahitosh Mandal, R. Weber, S. Lippman, 2008, Cancer.

RSK Promotes Prostate Cancer Progression in Bone through ING3, CKAP2, and PTK6-Mediated Cell Survival

Jian Kuang, L. Yu-Lee, Sue-Hwa Lin, 2014, Molecular Cancer Research.

A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma

C. Ng, P. Hwu, L. Camacho, 2012, Melanoma research.

ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma

Douglas B. Evans, Huamin Wang, S. Kopetz, 2011, PloS one.

The Molecular Biology of Colorectal Carcinoma

J. Jessup, G. Gallick, Bo Liu, 2002 .

Molecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancer.

C. Logothetis, Jeri Kim, Sue-Hwa Lin, 2013, Cancer discovery.

Molecular Classifi cation of Prostate Cancer Progression : Foundation for Marker-Driven Treatment of Prostate Cancer

C. Logothetis, Jeri Kim, Sue-Hwa Lin, 2013 .

Steps in prostate cancer progression that lead to bone metastasis

G. Gallick, F. Dayyani, Jung-kang Jin, 2011, International journal of cancer.

The Role of Oncogene Activation in Tumor Progression

G. Gallick, M. J. Gray, 2010 .

The Role of the Guanine Nucleotide Exchange Factor Tiam1 in Cellular Migration, Invasion, Adhesion and Tumor Progression

Meghan E. Minard, J. Price, G. Gallick, 2004, Breast Cancer Research and Treatment.

Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.

Huamin Wang, D. McConkey, J. Abbruzzese, 2009, Cancer research.

Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents

Michael A. Davies, Gordon B. Mills, John M. Mariadason, 2012, Clinical Cancer Research.

Src, chemoresistance and epithelial to mesenchymal transition: are they related?

G. Gallick, Ami N. Shah, 2007, Anti-cancer drugs.

Potential Roles of Activated Proto-Oncogenes in Malignant Progression

G. Gallick, 1989 .

Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.

I. Wistuba, C. Creighton, J. Rodriguez-Canales, 2018, Cancer research.

The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK+ T-cell lymphoma

Yao‐Hua Song, S. Alkan, P. Shi, 2015, Molecular Cancer.

Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma.

Liz Y. Han, A. Sood, C. Landen, 2006, Cancer research.

Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.

J. Trevino, G. Gallick, M. Nilsson, 2005, Cancer research.

Vascular endothelial growth factor is upregulated by interleukin-1β in human vascular smooth muscle cells via the P38 mitogen-activated protein kinase pathway

L. Ellis, Wenbiao Liu, N. Reinmuth, 2004, Angiogenesis.

Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases.

S. Curley, G. Gallick, N. Han, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Ligand‐independent activation of MET through IGF‐1/IGF‐1R signaling

C. Logothetis, G. Gallick, Jian Song, 2013, International journal of cancer.

Regulatory role of c-Met in insulin-like growth factor-I receptor–mediated migration and invasion of human pancreatic carcinoma cells

Lee M Ellis, L. Ellis, Wenbiao Liu, 2006, Molecular Cancer Therapeutics.

Expression of p21ras Gene Products in Fresh Primary and Metastatic Human Tumor Tissue

R. Kurzrock, J. Gutterman, G. Gallick, 1986 .

Discovery, development, and testing of substrates and inhibitors of pp60c-SRC

J. McMurray, H. Saya, V. Levin, 1995 .

Analysis of PllO * " " " " * ' Tyrosine Protein Kinase Activity in Various Subtypes of Philadelphia Chromosome-positive Cells from Chronic Myelogenous Leukemia Patients 1

R. Kurzrock, J. Gutterman, S. Maxwell, 2006 .

Src protein kinase pp60c-src influences adhesion stabilization of HT-29 colon carcinoma cells to extracellular matrix components under dynamic conditions of laminar flow.

G. Nicolson, G. Gallick, J. Haier, 2002, Journal of experimental therapeutics & oncology.

Activation of Src kinase in primary colorectal carcinoma

Heike Allgayer, H. Allgayer, S. Curley, 2002, Cancer.

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells

P. Friedl, P. Troncoso, John W. Davis, 2015, Oncotarget.

Src Family Kinases as Regulators of Angiogenesis: Therapeutic Implications

G. Gallick, D. Lesslie, Donald P. Lesslie, 2005 .

Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor.

L. Ellis, Wenbiao Liu, G. Gallick, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice

Douglas B. Evans, Huamin Wang, J. Fleming, 2009, Nature Protocols.

A ROR1-HER3-LncRNA signaling axis modulates the Hippo-YAP pathway to regulate bone metastasis

Jun Yao, Yan Zhou, M. Hung, 2017, Nature Cell Biology.

Src signaling pathways in prostate cancer

P. Corn, G. Gallick, J. Araujo, 2014, Cancer and Metastasis Reviews.

Proteomics Profiling of Exosomes from Primary Mouse Osteoblasts under Proliferation versus Mineralization Conditions and Characterization of Their Uptake into Prostate Cancer Cells.

J. Vykoukal, D. Hawke, R. Satcher, 2017, Journal of proteome research.

Novel therapies for metastatic castrate-resistant prostate cancer.

C. Logothetis, P. Corn, G. Gallick, 2011, Journal of the National Cancer Institute.

Extracellular signal-regulated kinase activation is required for up-regulation of vascular endothelial growth factor by serum starvation in human colon carcinoma cells.

L. Ellis, G. Gallick, Y. Jung, 1999, Cancer research.

Treatment for Advanced Tumors: Src Reclaims Center Stage

G. Gallick, J. Summy, 2006, Clinical Cancer Research.

Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers.

Peter F Thall, Gordon B Mills, Michael T Deavers, 2003, Gynecologic oncology.

Sustained Src inhibition results in signal transducer and activator of transcription 3 (STAT3) activation and cancer cell survival via altered Janus-activated kinase-STAT3 binding.

F. Johnson, G. Gallick, Banibrata Sen, 2009, Cancer research.

Src Continues Aging: Current and Future Clinical Directions

S. Kopetz, G. Gallick, Scott Kopetz, 2007, Clinical Cancer Research.

Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer

B. Czerniak, C. Logothetis, P. Corn, 2015, Clinical Cancer Research.

The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials

C. Logothetis, P. Corn, G. Gallick, 2011, Expert opinion on investigational drugs.

Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model.

Zhengxin Wang, J. Gelovani, A. Najjar, 2008, Cancer research.

Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.

F. Lee, N. Donato, D. Hong, 2006, The American journal of pathology.

Small-molecule protein tyrosine kinase inhibitors for the treatment of metastatic prostate cancer.

P. Corn, Sue-Hwa Lin, A. Zurita, 2012, Future medicinal chemistry.

In vivo intracellular signaling as a marker of antiangiogenic activity.

L. Ellis, C. Bucana, G. Mcmahon, 2001, Cancer research.

Advances in Brief Extracellular Signal-regulated Kinase Activation Is Required for Up-Regulation of Vascular Endothelial Growth Factor by Serum Starvation in Human Colon Carcinoma Cells 1

L. Ellis, Wenbiao Liu, Y. Jung, 1999 .

Src activation regulates anoikis in human colon tumor cell lines

A. Kraker, D. McConkey, D. Siwak, 2002, Oncogene.

Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer.

S. Curley, M. Talamonti, M. Roh, 1993, The Journal of clinical investigation.

A tyrphostin-derived inhibitor of protein tyrosine kinases: isolation and characterization.

J. McMurray, L. Ramdas, G. Gallick, 1995, Archives of biochemistry and biophysics.

Src activation by β-adrenoreceptors is a key switch for tumor metastasis

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2012, Nature Communications.

Src activation by b-adrenoreceptors is a key switch for tumour metastasis

David B Jackson, Theodoros G. Soldatos, David B. Jackson, 2013 .

Plasticity in urokinase-type plasminogen activator receptor (uPAR) display in colon cancer yields metastable subpopulations oscillating in cell surface uPAR density--implications in tumor progression.

D. Boyd, J. Trevino, Y. Kitadai, 2006, Cancer research.

Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy

A. Sood, Yan Shi, C. Ivan, 2015, Oncotarget.

Expression of p21ras in fresh primary and metastatic human colorectal tumors.

R. Kurzrock, J. Gutterman, R. Arlinghaus, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.

Xiaoping Zhou, C. Logothetis, K. Fujiwara, 2017, Developmental cell.

Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment

P. Troncoso, C. Logothetis, P. Corn, 2021, Clinical Cancer Research.

Dasatinib combined with docetaxel for castration‐resistant prostate cancer

A. Armstrong, C. Logothetis, E. Posadas, 2012, Cancer.

BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation12

E. Jonasch, C. Wood, P. Lin, 2017, Neoplasia.

Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity.

G. Sonpavde, M. Galsky, Liang Cheng, 2016, Urologic oncology.

Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer

C. Logothetis, P. Corn, Sue-Hwa Lin, 2020, Cancers.

Extracellular Alix regulates integrin‐mediated cell adhesions and extracellular matrix assembly

Xiaoping Zhou, M. Kloc, Sue-Hwa Lin, 2008, The EMBO journal.

Colorectal Adenoma Stem-like Cell Populations: Associations with Adenoma Characteristics and Metachronous Colorectal Neoplasia

Chiu-Hsieh Hsu, P. Lance, D. Roe, 2013, Cancer Prevention Research.

Molecular Profiling of Direct Xenograft Tumors Established from Human Pancreatic Adenocarcinoma After Neoadjuvant Therapy

R. Hwang, Huamin Wang, D. McConkey, 2012, Annals of Surgical Oncology.

Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer.

C. Logothetis, B. Liu, P. Corn, 2015, Cancer research.

Pre-clinical mouse models of human prostate cancer and their utility in drug discovery.

S. J. Kim, G. Gallick, Serk In Park, 2010, Current protocols in pharmacology.

αvβ3 Integrin Antagonist S247 Decreases Colon Cancer Metastasis and Angiogenesis and Improves Survival in Mice

L. Ellis, O. Stoeltzing, Wenbiao Liu, 2003 .

Expression of epidermal growth factor receptor and associated glycoprotein on cultured human brain tumor cells

W. Yung, J. Gutterman, S. Maxwell, 1986, Journal of cellular biochemistry.

Regulation of Cdc25C by ERK-MAP Kinases during the G2/M Transition

M. Kirschner, P. Stukenberg, Ruoning Wang, 2007, Cell.

A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis.

D. Boyd, G. Gallick, Sun-jin Kim, 2003, The American journal of pathology.

GWAS Meets Microarray: Are the Results of Genome-Wide Association Studies and Gene-Expression Profiling Consistent? Prostate Cancer as an Example

Ivan P. Gorlov, Christopher J. Logothetis, Olga Y. Gorlova, 2009, PloS one.

Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.

R. Bast, C. Bucana, J. Wiener, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.

Liz Y. Han, A. Sood, C. Landen, 2006, Journal of the National Cancer Institute.

Antivascular Effects of EphA 2 Reduction With an Agonistic Antibody in Ovarian Cancer

Liz Y. Han, A. Sood, C. Landen, 2006 .

Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.

Lee M Ellis, L. Ellis, O. Stoeltzing, 2003, Cancer research.

Organelle-Derived Acetyl-CoA Promotes Prostate Cancer Cell Survival, Migration, and Metastasis via Activation of Calmodulin Kinase II.

L. Nutt, M. Titus, L. Yu-Lee, 2018, Cancer research.

Unravelling the pivotal role of Alix in MVB sorting and silencing of the activated EGFR.

Xiaoping Zhou, J. Kuang, G. Gallick, 2015, The Biochemical journal.

Cabozantinib Reverses Renal Cell Carcinoma–mediated Osteoblast Inhibition in Three-dimensional Coculture In Vitro and Reduces Bone Osteolysis In Vivo

D. Harrington, R. Satcher, T. Pan, 2020, Molecular Cancer Therapeutics.

Transfection of activated c-H-rasEJ/pSV2neo or pSV2neo genes into rat mammary cells: rapid stimulation of clonal diversification of spontaneous metastatic and cell-surface properties.

G. Nicolson, M. Tainsky, G. Gallick, 1992, Oncogene.

Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis

Sue-Hwa Lin, G. Gallick, Jian Song, 2014, Oncogene.

Targeting Constitutively Activated β1 Integrins Inhibits Prostate Cancer Metastasis

C. Logothetis, E. Yeh, L. Yu-Lee, 2013, Molecular Cancer Research.

Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.

S. J. Kim, G. Gallick, M. H. Herynk, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity.

N. Donato, P. Steck, M. Rosenblum, 1989, The Journal of biological chemistry.

Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival

L. Ellis, Wenbiao Liu, N. Reinmuth, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

P85gag-mos encoded by ts110 Moloney murine sarcoma virus: rapid at the restrictive temperature.

R. Arlinghaus, G. Gallick, L. Stanker, 1983, The Journal of general virology.

SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy.

F. Johnson, G. Gallick, Faye M Johnson, 2007, Anti-cancer agents in medicinal chemistry.

Signal Transduction Targeting Constitutively Activated b 1 Integrins Inhibits Prostate Cancer Metastasis

C. Logothetis, E. Yeh, L. Yu-Lee, 2015 .

Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways

C. Logothetis, M. Gottardis, G. Gallick, 2012, PloS one.

The DiFi Rectal Carcinoma Cell Line from a Familial Adenomatous Polyposis Patient: An In Vitro Model System to Study Genetic Changes in Colorectal Cancer

G. Thomas, B. Levin, B. Boman, 1990 .

Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells.

L. Ellis, O. Stoeltzing, N. Reinmuth, 2003, Cancer research.

Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma

S. Corey, E. Kleinerman, A. Sood, 2008, Molecular Cancer Therapeutics.

Integrin Antagonist S 247 Decreases Colon Cancer Metastasis and Angiogenesis and Improves Survival in Mice 1

L. Ellis, O. Stoeltzing, Wenbiao Liu, 2003 .

Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells.

G. Gallick, M. H. Herynk, N. Parikh, 2007, Journal of experimental therapeutics & oncology.

Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated β-catenin

R. Radinsky, G. Gallick, M. H. Herynk, 2004, Clinical & Experimental Metastasis.

Combined activity of dasatinib (BMS-354825) and oxaliplatin in an orthotopic model of metastatic colorectal carcinoma

F. Lee, N. Donato, D. Hong, 2006 .

Growth Inhibition of Human Colorectal Carcinoma Cell Lines by Tumor Necrosis Factor‐Alpha Correlates with Reduced Activity of pp60c‐src

G. Gallick, C. L. Novotny-Smith, 1992, Journal of immunotherapy : official journal of the Society for Biological Therapy.

HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas

L. Ellis, G. Semenza, G. Gallick, 2005, Oncogene.

Autocrine growth stimulation by transforming growth factor-α in human non-small cell lung cancer

A. Gazdar, J. Roth, K. Fang, 1992 .

P85: a gag-mos Polyprotein Encoded by ts110 Moloney Murine Sarcoma Virus

R. Arlinghaus, G. Gallick, W. Kloetzer, 1983, Journal of virology.

Benzodiazepine compounds as inhibitors of the src protein tyrosine kinase: screening of a combinatorial library of 1,4-benzodiazepines.

L. Ramdas, G. Sun, J. Ellman, 1999, Archives of biochemistry and biophysics.

Impact of Insulin-Like Growth Factor Receptor-I Function on Angiogenesis, Growth, and Metastasis of Colon Cancer

L. Ellis, O. Stoeltzing, Wenbiao Liu, 2002, Laboratory Investigation.

Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells

L. Ellis, Meghan E. Minard, G. Gallick, 2006, Clinical & Experimental Metastasis.

Orthotopic and heterotopic generation of murine pancreatic cancer xenografts

Douglas B. Evans, Huamin Wang, G. Gallick, 2014 .

AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.

W. Yung, G. Gallick, Juinn-lin Liu, 2011, Neuro-oncology.

AFAP‐110 is required for actin stress fiber formation and cell adhesion in MDA‐MB‐231 breast cancer cells

C. Stehlik, D. Flynn, G. Gallick, 2007, Journal of cellular physiology.

Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts

L. Yu-Lee, K. Chu, X. Ye, 2010, Oncogene.

RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B

W. Bornmann, C. Wu, L. Yu-Lee, 2014, Oncogene.

Down-regulation of Vascular Endothelial Growth Factor in a Human Colon Carcinoma Cell Line Transfected with an Antisense Expression Vector Specific for c-src *

L. Ellis, Wenbiao Liu, C. Bucana, 1998, The Journal of Biological Chemistry.

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells

P. Friedl, P. Troncoso, John W. Davis, 2015 .

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells

P. Friedl, P. Troncoso, John W. Davis, 2015 .

The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model

John G. Collard, Meghan E. Minard, G. Gallick, 2005, Oncogene.

SRC as a potential therapeutic target in solid tumor oncology.

G. Gallick, 2004, Clinical advances in hematology & oncology : H&O.

Modulation of soluble c-Met, bone turnover markers, angiogenic factors, and c-Met in men with mCRPC treated with cabozantinib.

C. Logothetis, S. Tu, A. Zurita, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Loss of tyrosine phosphatase‐dependent inhibition promotes activation of tyrosine kinase c‐Src in detached pancreatic cells

G. Gallick, C. Baker, J. Summy, 2010, Molecular carcinogenesis.

Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.

G. Gallick, N. Parikh, Charles A. Staley, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Novel therapies for metastatic castrate-resistant prostate cancer.

C. Logothetis, P. Corn, G. Gallick, 2011, Journal of the National Cancer Institute.

Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer.

C. Logothetis, B. Liu, P. Corn, 2015, Cancer Research.

Correlation of dasatinib (DAS) peak levels with interleukin-8 (IL-8) and monocyte chemotactic protein-1 (MCP-1) levels in patients with castration-resistant progressive prostate cancer (CRPC).

C. Logothetis, Jerry T. Thompson, G. Gallick, 2010 .

BMP4 promotes prostate tumor growth in bone through osteogenesis.

R. Satcher, L. Yu-Lee, Sue-Hwa Lin, 2011, Cancer research.

Steps in prostate cancer progression that lead to bone metastasis

G. Gallick, F. Dayyani, Jung-kang Jin, 2011, International journal of cancer.

Ligand‐independent activation of MET through IGF‐1/IGF‐1R signaling

C. Logothetis, G. Gallick, Jian Song, 2013, International journal of cancer.